BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 19390314)

  • 1. Late effects of Hodgkin's disease and its treatment.
    Ng AK; Mauch PM
    Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Aleman BM; van Leeuwen FE
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
    van der Maazen RW; Raemaekers JM
    Curr Opin Oncol; 2006 Nov; 18(6):660-6. PubMed ID: 16988591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review.
    van Dorp W; van Beek RD; Laven JS; Pieters R; de Muinck Keizer-Schrama SM; van den Heuvel-Eibrink MM
    Hum Reprod Update; 2012; 18(1):12-28. PubMed ID: 21896559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term complications of lymphoma and its treatment.
    Ng AK; LaCasce A; Travis LB
    J Clin Oncol; 2011 May; 29(14):1885-92. PubMed ID: 21483015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late treatment related complications of Hodgkin's disease].
    Henry-Amar M; Gisselbrecht C
    Rev Prat; 1998 May; 48(10):1092-7. PubMed ID: 9781154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
    Ng AK
    Br J Haematol; 2011 Jul; 154(1):23-31. PubMed ID: 21539537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmalignant complications of therapy for Hodgkin's disease.
    Hohl RJ; Schilsky RL
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):331-43. PubMed ID: 2663831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late complications of Hodgkin's disease management.
    Young RC; Bookman MA; Longo DL
    J Natl Cancer Inst Monogr; 1990; (10):55-60. PubMed ID: 2189477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.
    Bar Ad V; Paltiel O; Glatstein E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1472-9. PubMed ID: 19028275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late complications of treatment for Hodgkin's disease in children and adolescents].
    Balwierz W; Moryl-Bujakowska A
    Przegl Lek; 2006; 63(1):31-6. PubMed ID: 16892897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
    Streit M; Thiel E; Kreuser ED
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1093-9. PubMed ID: 7641593
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Balwierz W; Moryl-Bujakowska A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Sopyło B; Stańczak E; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Odój T; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Kołtan S; Krawczuk-Rybak M; Muszyńska-Rosłan K; Zuj G;
    Przegl Lek; 2006; 63(1):25-8. PubMed ID: 16892895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late complications after treatment of Hodgkin's disease].
    Lund MB; Kongerud J; Boe J; Ihlen H; Forfang K; Abrahamsen AF; Nome O
    Tidsskr Nor Laegeforen; 1999 Mar; 119(7):933-7. PubMed ID: 10210953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.
    Hancock SL; Hoppe RT
    Semin Radiat Oncol; 1996 Jul; 6(3):225-242. PubMed ID: 10717180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Second malignancies in patients treated for Hodgkin's disease].
    Keresztes K; Miltényi Z; András C; Illés A
    Magy Onkol; 2002; 46(3):247-51. PubMed ID: 12368920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.